FdaApplication
NDA 216196
Identifiers
- fda_app_no: NDA216196
Properties
| Property | Value |
|---|---|
| applicant_name | AGIOS PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2022-02-17 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AQVESME | MITAPIVAT SULFATE | EQ 100MG BASE | TABLET;ORAL |
| PYRUKYND | MITAPIVAT SULFATE | EQ 5MG BASE | TABLET;ORAL |
| PYRUKYND | MITAPIVAT SULFATE | EQ 50MG BASE | TABLET;ORAL |
| PYRUKYND | MITAPIVAT SULFATE | EQ 20MG BASE | TABLET;ORAL |
4 products